| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 11.05.
| ISTA Pharma presents Prolensa Phase 3 clinical data | | 1 | Pharma Bus Review |
| 10.05.
| ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting | | 34 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 05/10/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today presented results from the second of two Phase 3 studies of PROLENSA (bromfenac ophthalmic solution), the...
Mehr lesen zu:
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting | |
| 05.05.
| ISTA Pharmaceuticals Posts a Surprise Profit | | - | Motley Fool |
| 04.05.
| ISTA PHARMACEUTICALS INC - 10-Q, Quarterly Report | | - | SEC Filings |
| 03.05.
| ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results | | 13 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 05/03/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today reported on recent events and financial results for the quarter ended March 31, 2012.
Recent Events
On...
Mehr lesen zu:
ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results | |
| 01.05.
| ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis | | 41 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 05/01/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) announced today positive results from its Phase 2 randomized, placebo-controlled, parallel-group environmental clinical...
Mehr lesen zu:
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis | |
| 01.05.
| ISTA Pharma (ISTA) Reports Positive Results from BEPOSONE Phase 2 | | - | StreetInsider.com |
| 27.04.
| ISTA PHARMACEUTICALS INC - 10-K/A, Annual Report | | - | SEC Filings |
| 23.04.
| Bausch + Lomb, ISTA Pharma (ISTA) Get Early HSR Termination | | 3 | StreetInsider.com |
| 23.04.
| Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period | | - | Benzinga.com |
| 23.04.
|
Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period | | 32 | MarketWire |
| MADISON, NJ and IRVINE, CA -- (Marketwire) -- 04/23/12 -- Bausch + Lomb, the global eye health company, and ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced that they received early termination...
Mehr lesen zu:
Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period | |
| 23.04.
| ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12 | | 1 | StreetInsider.com |
| 23.04.
| ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 American Society of Cataract and Refractive Surgery (ASCRS) Symposium and Congress | | 11 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 04/23/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today presented results from one of two Phase 3 studies of PROLENSA (bromfenac ophthalmic solution), the Company's...
Mehr lesen zu:
ISTA Pharmaceuticals Highlights PROLENSA(TM) Clinical Data at the 2012 American Society of Cataract and Refractive Surgery (ASCRS) Symposium and Congress | |
| 03.04.
| ISTA Pharmaceuticals, Inc. (ISTA) Investor Lawsuit Against Buyout Announced by Shareholders Foundation | | 40 | MarketWire |
| SAN DIEGO, CA -- (Marketwire) -- 04/03/12 -- The Shareholders Foundation, Inc. announces that an investor filed a lawsuit in State Court for current stockholders of ISTA Pharmaceuticals, Inc. (ISTA)...
Mehr lesen zu:
ISTA Pharmaceuticals, Inc. (ISTA) Investor Lawsuit Against Buyout Announced by Shareholders Foundation | |
| 02.04.
| Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc. | | 53 | PR Newswire |
| BALA CYNWYD, Pa., April 2, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ISTA Pharmaceuticals, Inc....
Mehr lesen zu:
Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc. | |
| 29.03.
| The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb | | 68 | PR Newswire |
| NEW YORK, March 28, 2012 /PRNewswire/ --Levi & Korsinsky is investigating the Board of Directors of ISTA Pharmaceuticals, Inc. ("ISTA" or the "Company") (Nasdaq: ISTA) for possible breaches of fiduciary...
Mehr lesen zu:
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of ISTA Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bausch + Lomb | |
| 28.03.
| Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc. | | 42 | Business Wire |
| Law Offices of Howard G. Smith announces that it is investigating
potential claims against the Board of Directors of ISTA Pharmaceuticals,
Inc. ("ISTA" or the "Company")...
Mehr lesen zu:
Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc. | |
| 28.03.
| Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb | | 36 | Business Wire |
| The law firm of Brower Piven, A Professional Corporation, has commenced
an investigation into possible breaches of fiduciary duty to current
shareholders of ISTA Pharmaceuticals...
Mehr lesen zu:
Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb | |
| 28.03.
| Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc. | | 87 | Business Wire |
| Glancy Binkow & Goldberg LLP announces that it is investigating
potential claims against the Board of Directors of ISTA Pharmaceuticals,
Inc. ("ISTA" or the "Company")...
Mehr lesen zu:
Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc. | |
| 28.03.
| The Law Firm of Weiss & Lurie Investigates ISTA Pharmaceuticals, Inc. | | 65 | Business Wire |
| Weiss & Lurie, a national class action and shareholder rights law firm
with offices in New York City and Los Angeles, is investigating possible
breaches of fiduciary duty...
Mehr lesen zu:
The Law Firm of Weiss & Lurie Investigates ISTA Pharmaceuticals, Inc. | |
